Bailong Chuangyuan(SH:605016) Ge Long Hui A P P·2026-02-11 07:39Core Viewpoint - The company, Bailong Chuangyuan (605016.SH), has announced the establishment of a wholly-owned subsidiary, Bailong Chuangyuan (Nanjing) Biotechnology Co., Ltd., with an investment of 10 million RMB to enhance its international market presence and sales team [1] Group 1: Investment and Strategic Development - The investment of 10 million RMB is aimed at strengthening the overseas sales team and actively exploring international markets [1] - The company will leverage the geographical advantages of Nanjing to expand its overseas customer base and enhance technical exchanges [1] Group 2: Operational Impact - The establishment of the Nanjing subsidiary is expected to increase the company's export revenue and improve its overall profitability by enhancing overseas customer service capabilities [1]